Agilent, GKSB-317, AdvanceBio 2-AB G1 / A2G1 N-glycan Standard

AdvanceBio 2-AB G1 / A2G1 N-glycan Standard. N-glycan (asialo-, mono-galactosylated biantennary) labeled with 2-aminobenzamide (2-AB), for use as a qualitative standard in applications such as liquid chromatography (LC). Alternative glycan name: NA2G1.

Specifications:
Chemical Structure:
Label: 2-AB
Monoisotopic Mass: MWGlycan + 120.06875 = 1598.6081
Name: G1
Oxford Name: A2G1
Standard Type: Complex-type Native N-Glycan
Unit: 100 pmol

**********The following product description is generated by AI and is for reference only. If you have any questions, please contact customer service.**********
This purified N-glycan standard offers high-quality 2-aminobenzamide (2-AB) labeled G1 and A2G1 glycan structures for use in analytical workflows. Designed for accurate identification, quantitation, and method optimization, this standard is ideal for routine glycan analysis in biopharmaceutical development, QC, and glycoprotein characterization. Researchers working on monoclonal antibodies, therapeutic proteins, or biosimilars will benefit from its defined composition and stringent quality controls.

The 2-AB labeling enables sensitive fluorescence detection and seamless integration into both HILIC-UPLC and HPLC workflows. The standard is fully compatible with Agilent AdvanceBio Glycan Mapping columns, AssayMAP platforms, and LC-MS workflows, providing consistent retention times and reliable performance. It is suitable for users establishing system suitability controls, calibrating glycan mapping methods, or benchmarking glycan profiling accuracy across different analytical platforms.

This reference material supports robust structure assignment, retention time calibration, and system suitability evaluation in regulatory-compliant environments. When used alongside other Agilent glycan standards and sample preparation kits, it streamlines workflow standardization and result comparability. Its application extends to labs engaged in therapeutic glycoprotein characterization, lot release testing, and advanced glycan structural elucidation, reinforcing confidence in data integrity and regulatory submissions.